[Treatment of pain in diabetic polyneuropathy].
Ziegler
D
D
Klinische Abteilung, Diebetes-Forschungsinstitut, Universität, Düsseldorf.
Gries
F A
FA
D000700:Analgesics / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D003929:Diabetic Neuropathies / Q000503:physiopathology*; D005732:Gangliosides / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008042:Linolenic Acids / Q000627:therapeutic use; D008801:Mexiletine / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy* / Q000209:etiology
D000700:Analgesics; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D005732:Gangliosides; D008042:Linolenic Acids; D008801:Mexiletine; D002220:Carbamazepine; D008012:Lidocaine
Schmerzbehandlung bei Polyneuropathia diabetica.